Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

BACKGROUND: Two large clinical trials have shown a reduced rate of breast cancer development in high-risk women in the initial 5 years of follow-up after use of aromatase inhibitors (MAP.3 and International Breast Cancer Intervention Study II [IBIS-II]). Here, we report blinded long-term follow-up r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuzick, Jack, Sestak, Ivana, Forbes, John F, Dowsett, Mitch, Cawthorn, Simon, Mansel, Robert E, Loibl, Sibylle, Bonanni, Bernardo, Evans, D Gareth, Howell, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961114/
https://www.ncbi.nlm.nih.gov/pubmed/31839281
http://dx.doi.org/10.1016/S0140-6736(19)32955-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961114/
https://www.ncbi.nlm.nih.gov/pubmed/31839281
http://dx.doi.org/10.1016/S0140-6736(19)32955-1

Ejemplares similares